Showing results (1661-1670 of 3,638) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|January 3, 2025
The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational studyLeonor Vasconcelos de Matos, Margarida Borges, Ana Teresa Oliveira, et al.
Breast (Edinburgh, Scotland)|February 21, 2025
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systemsMarcelo Antonini, André Mattar, Denise Joffily Pereira da Costa Pinheiro, et al.
Breast (Edinburgh, Scotland)|February 23, 2025
Diagnostic delay in women with cancer: What do we know and which factors contribute?Liza A Hoveling, Melinda Schuurman, Sabine Siesling, et al.
Breast (Edinburgh, Scotland)|February 25, 2025
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancerMonika Drobniene, Dominyka Breimelyte, Ieva Sadzeviciene, et al.
Breast (Edinburgh, Scotland)|January 14, 2025
Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases statusXuxiazi Zou, Hong-Liang Zou, Xuan Luo, et al.
Breast (Edinburgh, Scotland)|January 4, 2025
Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancerKe Liu, Guan-Qiao Li, Si-Qi Li, et al.
Breast (Edinburgh, Scotland)|March 22, 2025
Prognostic factors and treatment insights for metastatic malignant phyllode tumorsMengjia Han, Yunyi Zhang, Rong Lei, et al.
Breast (Edinburgh, Scotland)|March 8, 2025
Innovations in the localization techniques for non-palpable breast lesions: Make invisible visibleQuankun Lin, Qiwen Hou, Chenyu Zhang, et al.
Breast (Edinburgh, Scotland)|September 4, 2024
Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapyLei Ji, Xi Chen, Xiaoyan Qian, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Effect of different exercise types on quality of life in patients with breast cancer: A network meta-analysis of randomized controlled trialsLiang Li, Yutong Wang, Mingzhou Cai, et al.
Pageof 364